Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (1171-1180 of 1,298) with videos related to

Pageof 130
Sort By:
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Cell Reports. Medicine|March 18, 2026
Spatial tumor evolution panorama of ovarian cancerChenzhao Feng, Yunyi Yang, Guanchu Li, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Hepatology (Baltimore, Md.)|September 22, 2015
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinomaYun-Yong Park, Bo Hwa Sohn, Randy L Johnson, et al.
Clinical Chemistry|January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumorsKen Chen, Funda Meric-Bernstam, Hao Zhao, et al.
Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.
Cancer Cell|February 16, 2017
Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysJun Li, Wei Zhao, Rehan Akbani, et al.
The Journal of Experimental Medicine|January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Pageof 130

Showing results (1171-1180 of 1,298) with videos related to

Sort By:
Pageof 130
Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.
Cell Reports. Medicine|March 18, 2026
Spatial tumor evolution panorama of ovarian cancerChenzhao Feng, Yunyi Yang, Guanchu Li, et al.
Gynecologic Oncology|April 11, 2012
Perifosine plus docetaxel in patients with platinum and taxane resistant or refractory high-grade epithelial ovarian cancerSiqing Fu, Bryan T Hennessy, Chaan S Ng, et al.
Nature Communications|February 22, 2020
Immuno-genomic landscape of osteosarcomaChia-Chin Wu, Hannah C Beird, J Andrew Livingston, et al.
Cell Reports|December 26, 2019
miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast CancerDeepak Parashar, Anjali Geethadevi, Miriam Ragle Aure, et al.
Hepatology (Baltimore, Md.)|September 22, 2015
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinomaYun-Yong Park, Bo Hwa Sohn, Randy L Johnson, et al.
Clinical Chemistry|January 29, 2015
Clinical actionability enhanced through deep targeted sequencing of solid tumorsKen Chen, Funda Meric-Bernstam, Hao Zhao, et al.
Cell|March 5, 2021
An expanded universe of cancer targetsWilliam C Hahn, Joel S Bader, Theodore P Braun, et al.
Cancer Cell|February 16, 2017
Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysJun Li, Wei Zhao, Rehan Akbani, et al.
The Journal of Experimental Medicine|January 27, 2019
Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancerMatthew L Hedberg, Noah D Peyser, Julie E Bauman, et al.
Pageof 130